Zürcher Nachrichten - US panel weighs authorizing Covid vaccines for youngest children

EUR -
AED 4.316068
AFN 75.78368
ALL 95.590345
AMD 433.921011
ANG 2.103199
AOA 1078.693153
ARS 1639.785212
AUD 1.624081
AWG 2.115085
AZN 1.998447
BAM 1.953692
BBD 2.367425
BDT 144.224377
BGN 1.960098
BHD 0.443342
BIF 3496.940129
BMD 1.175047
BND 1.48805
BOB 8.122098
BRL 5.804148
BSD 1.175422
BTN 110.788156
BWP 15.737751
BYN 3.321717
BYR 23030.922895
BZD 2.364009
CAD 1.602171
CDF 2720.234209
CHF 0.915114
CLF 0.026583
CLP 1046.250228
CNY 7.992494
CNH 7.994215
COP 4395.921653
CRC 539.208999
CUC 1.175047
CUP 31.138748
CVE 110.718804
CZK 24.309497
DJF 208.829292
DKK 7.472536
DOP 69.974145
DZD 155.20245
EGP 61.946583
ERN 17.625706
ETB 184.837228
FJD 2.569065
FKP 0.864214
GBP 0.865099
GEL 3.14908
GGP 0.864214
GHS 13.242649
GIP 0.864214
GMD 85.778323
GNF 10313.979512
GTQ 8.975086
GYD 245.920458
HKD 9.203498
HNL 31.268177
HRK 7.538985
HTG 153.949298
HUF 356.459886
IDR 20367.502417
ILS 3.409229
IMP 0.864214
INR 110.911284
IQD 1539.311683
IRR 1542719.319578
ISK 143.802053
JEP 0.864214
JMD 185.140228
JOD 0.833171
JPY 184.059961
KES 151.757262
KGS 102.723202
KHR 4714.873056
KMF 492.344575
KPW 1057.555194
KRW 1710.72734
KWD 0.361773
KYD 0.979526
KZT 544.33643
LAK 25792.283247
LBP 105225.46686
LKR 378.490323
LRD 215.562468
LSL 19.235691
LTL 3.469608
LVL 0.710774
LYD 7.437674
MAD 10.742863
MDL 20.222835
MGA 4894.071095
MKD 61.679754
MMK 2467.412574
MNT 4207.19177
MOP 9.480809
MRU 46.925498
MUR 54.88696
MVR 18.1603
MWK 2046.931705
MXN 20.277164
MYR 4.59457
MZN 75.083217
NAD 19.235747
NGN 1598.816408
NIO 43.130063
NOK 10.920412
NPR 177.26371
NZD 1.972799
OMR 0.451806
PAB 1.175412
PEN 4.062727
PGK 5.099342
PHP 71.029227
PKR 327.365667
PLN 4.227866
PYG 7194.237187
QAR 4.280702
RON 5.263274
RSD 117.383642
RUB 87.720656
RWF 1716.15627
SAR 4.436151
SBD 9.438281
SCR 16.52231
SDG 705.619296
SEK 10.86037
SGD 1.48966
SHP 0.877291
SLE 28.907303
SLL 24640.145375
SOS 671.539675
SRD 43.983217
STD 24321.10228
STN 24.999127
SVC 10.284902
SYP 129.899463
SZL 19.235297
THB 37.88334
TJS 10.984361
TMT 4.124415
TND 3.371797
TOP 2.829232
TRY 53.167497
TTD 7.951285
TWD 36.887663
TZS 3052.181577
UAH 51.470562
UGX 4396.218926
USD 1.175047
UYU 46.999286
UZS 14247.445607
VES 583.06901
VND 30915.488845
VUV 138.765659
WST 3.186155
XAF 655.238824
XAG 0.014727
XAU 0.000249
XCD 3.175623
XCG 2.118351
XDR 0.815968
XOF 653.912644
XPF 119.331742
YER 280.367229
ZAR 19.270304
ZMK 10576.837589
ZMW 22.391458
ZWL 378.364682
  • RBGPF

    0.0000

    63.18

    0%

  • CMSC

    -0.0300

    22.97

    -0.13%

  • RELX

    -1.4150

    34.335

    -4.12%

  • NGG

    -1.6500

    86.2

    -1.91%

  • BCE

    0.4000

    24.63

    +1.62%

  • BCC

    -0.2000

    74.04

    -0.27%

  • BP

    -0.7950

    43.835

    -1.81%

  • BTI

    -1.2850

    58.275

    -2.21%

  • RIO

    -2.0400

    103.47

    -1.97%

  • GSK

    0.1000

    50.63

    +0.2%

  • AZN

    -2.3100

    182.61

    -1.26%

  • JRI

    -0.0350

    13.135

    -0.27%

  • RYCEF

    -0.0500

    17.45

    -0.29%

  • CMSD

    -0.0100

    23.41

    -0.04%

  • VOD

    -0.3800

    15.75

    -2.41%

US panel weighs authorizing Covid vaccines for youngest children
US panel weighs authorizing Covid vaccines for youngest children / Photo: Frederic J. BROWN - AFP/File

US panel weighs authorizing Covid vaccines for youngest children

After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.

Text size:

Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.

Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."

Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.

Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.

They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.

Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.

But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.

There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.

White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.

Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.

Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.

Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.

Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."

S.Scheidegger--NZN